Extending the indications for TAVI to patients with asymptomatic severe aortic stenosis

Chairpersons: M.B. Leon, P. Pibarot
Panellists: E. Grube, F. Hellig, A. Linke

Learning Objectives

  • To understand in more detail the natural history of aortic stenosis
  • To explore the potential of minimally invasive valve therapy in the asymptomatic patient
  • To understand how earlier intervention could improve long-term outcomes

Presentations available when logged in:

  • Session objectives
  • The continuum of aortic stenosis: when does the real risk begin?
  • Identifying the at-risk patient – symptoms, biomarkers, imaging
  • Early intervention versus watchful waiting in asymptomatic severe aortic stenosis – current data
  • Potential advantages of TAVI over surgical aortic valve replacement in asymptomatic patients
  • What about moderate aortic stenosis and heart failure? Should we give TAVI the benefit of the doubt?
  • Session evaluation and key learnings